#332: Regulatory Strategy and the Advantage o...

Many early-stage medical device founders face a major dilemma: how do you prove regulatory maturity to investors and partners before you actually hold a final CE mark or FDA approval? Waiting until the end of a long development cycle creates significant commercial risk. By treati ...  Show more

In this episode, host Etienne Nichols sits down with Ali Samiian, founder and managing principal of Popular Access Advisors, to demystify the critical and often misunderstood world of MedTech reimbursement. Far too many early-stage medical device companies treat reimbursement as ...  Show more

Today's guest is Urvashi Tyagi, Advisor and Former CTO at ResMed. Urvashi joins us on today's podcast with Emerj Senior Matthew DeMello to discuss the unique challenges healthcare leaders face in driving software development efficiencies for medical devices and customer-facing ...

In this episode with Doreen Bedrossian Samaha, Global Clinical Application Manager at Erbe Elektromedizin GmbH, we explore the dynamic and evolving landscape of medical technology through the lens of a woman who is making significant contributions in the field. 

Listen ...

Today's guest is Nishtha Jain, Head of Innovation and Digital Technology at Takeda Pharmaceuticals. Nistha returns to the program to discuss the transformative impact of AI across the pharmaceutical value chain. She and Emerj Editorial Director Matthew DeMello explore how AI i ...

Today's guest is Nishtha Jain, Head of Innovation and Digital Technology at Takeda Pharmaceuticals. Her role expands across Global R&D Quality in driving digital and data initiatives from concept to execution, leveraging emerging technologies and design principles. She joins u ...